1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Training and Workforce Development Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR)" is currently closed and not accepting applications.
Training and Workforce Development Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) is sponsored by National Institute of General Medical Sciences (NIGMS) / National Institutes of Health (NIH).
This program encourages U.S. small businesses to engage in research and development activities with strong potential for commercialization, particularly in training and workforce development within biomedical and behavioral sciences.
Awards aim to stimulate technological innovation, meet federal R&D needs, increase private sector commercialization, and foster participation of underrepresented individuals in the biomedical research workforce. The program has two phases: Phase 1 establishes scientific/technical merit and commercialization potential, and Phase 2 continues R&D efforts.
Get alerted about grants like this
Get emailed when new opportunities from “National Institute of General Medical Sciences (NIGMS) / National Institutes of Health (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Training and Workforce Development Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) | National Institute of General Medical Sciences NIH has congressionally mandated set-aside programs for U.S. small businesses to engage in research and development activities that have strong potential for commercialization. Awards are intended to: Stimulate technological innovation.
Use small business to meet federal research and development needs. Increase private sector commercialization of innovations derived from federal research and development. Foster and encourage participation of individuals underrepresented in the biomedical research workforce in technological innovation.
The NIH SBIR/STTR program consists of two phases: Phase 1 (R41/R43) establishes the scientific and technical merit and feasibility as well as the potential for commercialization of the proposed research. Phase 2 (R42/R44) grant continues research or research and development (R&D) efforts initiated in Phase 1.
Training and Workforce Development Guidance The goal of NIGMS is to support innovative projects that could benefit the research communities related to its mission.
The Division of Training and Workforce Development supports the development of technologies and tools to enhance the research skills of post-high school individuals in the biomedical research workforce pathway or to increase the efficiencies of NIGMS research training programs.
The technologies may be new products or adaptations of existing products designed to be more efficient, cost-effective, culturally appropriate, and/or user-friendly in promoting the development of the biomedical research workforce. Examples for skills development projects include but are not limited to web-based resources, instructional software, interactive media, research-focused curriculum materials, and active learning toolkits.
Projects aimed at enhancing NIGMS training programs include but are not limited to technologies to track career outcomes of students and trainees and/or assist in the evaluation of workforce development programs (e.g., survey instruments and/or training activity tracking systems).
NIGMS does participate in the Commercialization Readiness Pilot (CRP) program designed to facilitate the transition of previously funded SBIR and STTR Phase 2 and Phase 2B projects to the commercialization stage by providing additional support for technical assistance. For information about the Training and Workforce Development NIGMS SBIR programs, e-mail Sailaja Koduri, Ph. D.
For information about NIGMS SBIR/STTR grants administration and management, email NIGMS_GAB_SBIR@nigms. nih. gov .
This page last updated on
According to the current listing, eligibility includes: U.S. small businesses. The Division of Training and Workforce Development supports projects that enhance the research skills of post-high school individuals in the biomedical research workforce pathway or increase the efficiencies of NIGMS research training programs. Confirm the full requirements in the official notice before applying.
The published deadline was May 13, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Training and Workforce Development Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) is funded by National Institute of General Medical Sciences (NIGMS) / National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
R21 Exploratory Technology Development is sponsored by National Institute of General Medical Sciences (NIGMS) / National Institutes of Health (NIH). This program supports exploratory technology development projects relevant to the NIGMS mission. It is suitable for novel, high-risk projects, and preliminary data is not required. The project outcome is a proof of concept study.
Focused Technology Research and Development (R01 Clinical Trial Not Allowed) is sponsored by National Institute of General Medical Sciences (NIGMS) / National Institutes of Health (NIH). This Notice of Funding Opportunity (NOFO) supports projects relevant to the NIGMS mission that focus solely on the development of technologies with the potential to enable the acquisition of biomedical knowledge. The project outcome is a working prototype of the technology.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleAfter a rare gap with zero active omnibus NOFOs, NIH has reissued its SBIR/STTR parent announcements — collapsing four solicitations into two, adding a Strategic Breakthrough bridge and a Commercialization Readiness Pilot, and reopening the funnel with a September 5, 2026 receipt date. Here are the exact solicitation numbers, the new budget ceilings, what actually changed, and how a small business should sequence its submission.
Read articleAfter an authorization lapse froze new SBIR/STTR awards for five months, NIH reopens its submission window on August 5, 2026, with a first standard deadline of September 8. Phase I awards run to $323,090, Phase II to $2,153,927, with published waiver topics reaching $700,000 and $3 million — and a new Phase IIB Strategic Breakthrough lane up to $30 million. Here is how the restarted omnibus is structured, why applying early matters more than usual this cycle, and how to position a life-science startup to win.
Read article